Cargando…
Structure, Distribution, and Genetic Profile of α-Synuclein and Their Potential Clinical Application in Parkinson’s Disease
Parkinson’s disease (PD), the second most common neurodegenerative disorder after Alzheimer’s disease, is characterized by the loss of nigral dopaminergic neurons. PD leads to a series of clinical symptoms, including motor and non-motor disturbances. α-synuclein, the major component of Lewy bodies,...
Autores principales: | Si, Xiaoli, Pu, Jiali, Zhang, Baorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Movement Disorder Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5435834/ https://www.ncbi.nlm.nih.gov/pubmed/28479587 http://dx.doi.org/10.14802/jmd.16061 |
Ejemplares similares
-
Alpha-Synuclein in Parkinson's Disease: From Pathogenetic Dysfunction to Potential Clinical Application
por: Xu, Lingjia, et al.
Publicado: (2016) -
Straight sinus dural arteriovenous fistula presenting with reversible parkinsonism: A case report and literature review
por: Pu, Jiali, et al.
Publicado: (2017) -
Genetic analysis of ATP13A2, PLA2G6 and FBXO7 in a cohort of Chinese patients with early-onset Parkinson’s disease
por: Shen, Ting, et al.
Publicado: (2018) -
In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease
por: Chahine, Lana M., et al.
Publicado: (2020) -
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
por: Tian, Chen, et al.
Publicado: (2019)